The National Medical Products Administration has issued an announcement identifying 50 batches of cosmetics that failed to meet regulatory requirements. Brands and importers should
The National Medical Products Administration has issued the 2026 cosmetics standards project plan, outlining upcoming standardization work. Companies in the cosmetics industry shou
China Customs has issued new measures governing the inspection, quarantine, and supervision of imported and exported cosmetics. Businesses involved in cross-border cosmetics trade
The General Administration of Customs has issued an announcement detailing the implementation of the new Measures for the Inspection, Quarantine and Supervision of Import and Expor
This document lists cosmetics that failed import inspection and were not admitted into China. Brands exporting cosmetics to China should review the list to identify potential compl
A safety warning has been issued for the cosmetic product ‘Shangmei Yuyan Suxian Liangfu Cream’ (filing number: 粤G妆网备字2022057538), whose filing was cancelled in July 2026. The clai
China Customs has published a draft measure for the supervision and administration of inspection of imported and exported cosmetics. The draft outlines requirements for inspection,
The Zhejiang Medical Products Administration has issued an announcement regarding risk control measures for certain cosmetics. The notice likely involves specific products and requ
This notice announces the results of the second round of cosmetic supervision and sampling inspections conducted by the Shanghai Municipal Drug Administration in 2026. Brands whose
China’s Cosmetic Supervision and Administration Regulation (CSAR) is the umbrella. 2026 added a mandatory national safety standard (GB 7916), a rewritten NCI dossier rule, and a registration/filing relief package (Announcement No. 70).